← Back
$DNLI All transactions

Denali Therapeutics Inc.

▼ SELL 10b5-1 Plan

$ Value

$7.4M

Shares

495,282

Price

$15

Filed

Jul 11

Insider

Name

Watts Ryan J.

Title

President and CEO

CIK

0001724310

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

253,071

Footnotes

Includes 177,940 Unvested RSUs. | The sales reported by the Reporting Person were made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 09/16/2024. The shares sold primarily relate to 455,282 stock options that expire on 08/21/2025. | The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $15.00 to $15.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. | The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. | The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. | 25% of the shares subject to the option will vest on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Filing Info

Accession No.

0001714899-25-000149

Form Type

4

Issuer CIK

0001714899

Watts Ryan J.'s History

Date Ticker Type Value
2026-01-06 DNLI $581K
2026-01-03 DNLI A $0
2026-01-03 DNLI A $0
2025-09-03 DNLI G $0
2025-07-09 DNLI M $310K
2025-07-09 DNLI M $211K
2025-07-09 DNLI $7.4M
2025-07-09 DNLI M $0
2025-07-09 DNLI M $0

Other Insiders at DNLI (90d)

No other insider activity at this issuer in the last 90 days.